QUANTIFICATION OF NORMAL DYSTROPHIN MESSENGER-RNA FOLLOWING MYOBLAST TRANSPLANTATION IN MDX MICE

被引:16
作者
ASSELIN, I
TREMBLAY, M
VILQUIN, JT
GUERETTE, B
TREMBLAY, JP
机构
[1] HOP ENFANTS JESUS,CTR RECH NEUROBIOL,QUEBEC CITY,PQ G1J 1Z4,CANADA
[2] UNIV LAVAL,DEPT ANAT,QUEBEC CITY,PQ,CANADA
[3] HOP ENFANTS JESUS,NEUROBIOL LAB,QUEBEC CITY,PQ,CANADA
[4] CHU LAVAL,CTR RECH IMMUNOL & RHUMATOL,ST FOY,PQ,CANADA
关键词
DYSTROPHIN; SARCOLEMMA; IMMUNOSUPPRESSION; MAE III; MUTAGENESIS;
D O I
10.1002/mus.880180909
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A mutagenesis RT-PCR method was used to detect normal dystrophin mRNA following the injection of normal myoblasts in mdx mice using two immunosuppressors, A specific sequence of the dystrophin mRNA (257 bp) was amplified by RT-PCR from the muscle total RNA, MaeIII digestion of the amplified products allowed us to distinguish the normal messenger of dystrophin from the dystrophic one and to establish the percentage of normal and of dystrophic (mdx) dystrophin mRNA, Normal dystrophin mRNA was detected using this technique in mdx muscles transplanted with histocompatible normal myoblasts, For this type of transplantation, no significant difference in the percentage of normal dystrophin mRNA was observed between immunosuppressed mice and those not immunosuppressed, No normal dystrophin mRNA was, however, observed in mdx mice following histoincompatible normal myoblast transplantation without immunosuppression, When such transplantations were done in mice immunosuppressed with cyclosporine or FK-506, normal dystrophin mRNA accounted for 31% and 36% of the total dystrophin mRNA, respectively, In fact, one animal immunosuppressed with FK-508 expressed as much as 57% of normal dystrophin mRNA, These results thus show that FK-506 makes it possible to restore dystrophin expression to a level comparable to that observed in DMD carriers that are usually asymptomatic. (C) 1995 John Wiley and Sons, Inc.
引用
收藏
页码:980 / 986
页数:7
相关论文
共 30 条
[1]   IMMUNOSTAINING OF SKELETAL AND CARDIAC-MUSCLE SURFACE-MEMBRANE WITH ANTIBODY AGAINST DUCHENNE MUSCULAR-DYSTROPHY PEPTIDE [J].
ARAHATA, K ;
ISHIURA, S ;
ISHIGURO, T ;
TSUKAHARA, T ;
SUHARA, Y ;
EGUCHI, C ;
ISHIHARA, T ;
NONAKA, I ;
OZAWA, E ;
SUGITA, H .
NATURE, 1988, 333 (6176) :861-863
[2]  
BONILLA E, 1988, AM J PATHOL, V133, P440
[3]   DUCHENNE MUSCULAR-DYSTROPHY - DEFICIENCY OF DYSTROPHIN AT THE MUSCLE-CELL SURFACE [J].
BONILLA, E ;
SAMITT, CE ;
MIRANDA, AF ;
HAYS, AP ;
SALVIATI, G ;
DIMAURO, S ;
KUNKEL, LM ;
HOFFMAN, EP ;
ROWLAND, LP .
CELL, 1988, 54 (04) :447-452
[4]   X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE [J].
BULFIELD, G ;
SILLER, WG ;
WIGHT, PAL ;
MOORE, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1189-1192
[5]   DYSTROPHIN IS LOCALIZED TO THE PLASMA-MEMBRANE OF HUMAN SKELETAL-MUSCLE FIBERS BY ELECTRON-MICROSCOPIC CYTOCHEMICAL STUDY [J].
CARPENTER, S ;
KARPATI, G ;
ZUBRZYCKAGAARN, E ;
BULMAN, DE ;
RAY, PN ;
WORTON, RG .
MUSCLE & NERVE, 1990, 13 (05) :376-380
[6]   CHARACTERIZATION OF DYSTROPHIN IN CARRIERS OF DUCHENNE MUSCULAR-DYSTROPHY [J].
CLERK, A ;
RODILLO, E ;
HECKMATT, JZ ;
DUBOWITZ, V ;
STRONG, PN ;
SEWRY, CA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 102 (02) :197-205
[7]  
COSSU G, 1965, J MED GENET, V2, P1
[8]  
EMERY A E, 1965, J Med Genet, V2, P1, DOI 10.1136/jmg.2.1.1
[9]   THE CONTRIBUTION OF EXOGENOUS CELLS TO REGENERATING SKELETAL-MUSCLE - AN ISOENZYME STUDY OF MUSCLE ALLOGRAFTS IN MICE [J].
GROUNDS, M ;
PARTRIDGE, TA ;
SLOPER, JC .
JOURNAL OF PATHOLOGY, 1980, 132 (04) :325-341
[10]  
GUERETTE B, IN PRESS MUSCLE NERV